P. Harper

发表

ICON2: randomised trial of single-agent carboplatin against three-drug combination of CAP (cyclophosphamide, doxorubicin, and cisplatin) in women with ovarian cancer

M. Buyse, E. Dreher, Torri, 1998, The Lancet.

Comparison of gemcitabine and carboplatin versus cisplatin and etoposide for patients with poor-prognosis small cell lung cancer

T. Eisen, D. Ferry, W. Qian, 2008, Thorax.

Incidence and predictors of ovarian function recovery (OFR) in breast cancer (BC) patients with chemotherapy-induced amenorrhea (CIA) who switched from tamoxifen to exemestane

H. Gabra, P. Vasey, S. Kaye, 2013 .

Five-day oral etoposide treatment for advanced small-cell lung cancer: randomized comparison with intravenous chemotherapy.

R. Souhami, R. Rudd, N. Gower, 1997, Journal of the National Cancer Institute.

A multicenter, randomized trial of flat dosing versus intrapatient dose escalation of single-agent carboplatin as first-line chemotherapy for advanced ovarian cancer: an SGCTG (SCOTROC 4) and ANZGOG study on behalf of GCIG.

G. Rustin, H. Gabra, P. Vasey, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Short report Final results of a randomised trial comparing Tomudex'® (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer

J. Zalcberg, C. Svensson, G. Pérez-Manga, 2005 .

Chemotherapy for the treatment of hormone‐refractory prostate cancer

S. Chowdhury, P. Harper, P. Harper, 2007, International journal of clinical practice.

Use of fluorodeoxyglucose positron emission tomography scans in patients with advanced germ cell tumour following chemotherapy: single‐centre experience with long‐term follow up *

C. Steer, C. Karapetis, D. Yip, 2003, Internal medicine journal.

The management of PS2 patients with advanced non‐small cell lung cancer

P. Harper, P. Harper, K. Cheong, 2006, International journal of clinical practice.

Gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage IIIB or IV non-small-cell lung cancer: a phase III randomized study of the London Lung Cancer Group.

W. Gregory, P. Johnson, W. Qian, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Decreased plasma half-life of cyclophosphamide during repeated high-dose administration

R. Souhami, R. Souhami, A. Mclean, 2004, Cancer Chemotherapy and Pharmacology.

PATTERNS OF HEMATOLOGICAL RECOVERY IN AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR SMALL CELL-CARCINOMA OF BRONCHUS, CARCINOMA OF THE OVARY, AND ACUTE-LEUKEMIA AND LYMPHOMA

D. Linch, R. Souhami, A. Goldstone, 1983 .

Management of the elderly patient with advanced  non‐small cell lung cancer

P. Harper, P. Harper, K. Cheong, 2006, International journal of clinical practice.

A randomised trial of low-dose/high-frequency chemotherapy as palliative treatment of poor-prognosis small-cell lung cancer: a Cancer research Campaign trial.

R. Souhami, M. Partridge, R. Rudd, 1996, British Journal of Cancer.

Assessment of 'quality of life' using a daily diary card in a randomised trial of chemotherapy in small-cell lung cancer.

R. Souhami, R. Rudd, N. Gower, 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

Neuroepithelioma—a rare malignant peripheral nerve tumor of primitive origin: Report of two new cases and a review of the literature

R. Souhami, J. Pringle, P. Harper, 1981, Cancer.

Adjuvant chemotherapy in non‐small cell lung cancer

P. Harper, K. Cheong, K. Chrystal, 2006, International journal of clinical practice.

No socioeconomic inequalities in ovarian cancer survival within two randomised clinical trials

M. Coleman, M. Parmar, A. Crook, 2014, British Journal of Cancer.

THE TREATMENT OF METASTATIC COLORECTAL CANCER

C. Karapetis, D. Yip, P. Harper, 1999, International journal of clinical practice.

Phase III randomised comparison of gemcitabine and carboplatin (GC) with mitomycin, ifosfamide and cisplatin (MIP) in advanced non-small cell lung cancer (NSCLC)

T. Eisen, W. Gregory, S. Lee, 2002 .

Combination chemotherapy with epirubicin, cisplatin and 5‐fluorouracil for the palliation of advanced gastric and oesophageal adenocarcinoma

M. Highley, R. Penson, R. Mason, 1994, The British journal of surgery.

A randomized trial comparing methotrexate and vinblastine (MV) with cisplatin, methotrexate and vinblastine (CMV) in advanced transitional cell carcinoma: results and a report on prognostic factors in a Medical Research Council study. MRC Advanced Bladder Cancer Working Party.

M. Parmar, P. Clark, G. Griffiths, 1998, British Journal of Cancer.

The response of cerebral metastases in small cell lung cancer to systemic chemotherapy.

H. Earl, R. Souhami, D. Geddes, 1990, British Journal of Cancer.

bronchus . small-cell carcinoma of the and without irradiation in combination chemotherapy with superior vena cava by Treatment of obstruction of the

J. Tobias, D. Geddes, P. Harper, 2022 .

Phase II trial of temozolomide in low-grade non-Hodgkin's lymphoma.

D. Crowther, E. Newlands, P. Woll, 1995, British Journal of Cancer.